Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
09 2020
Historique:
received: 03 03 2020
accepted: 03 08 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 5 11 2020
Statut: ppublish

Résumé

Despite the increasing adoption of insulin pumps and continuous glucose monitoring devices, most people with type 1 diabetes do not achieve their glycemic goals

Identifiants

pubmed: 32908282
doi: 10.1038/s41591-020-1045-7
pii: 10.1038/s41591-020-1045-7
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Banques de données

ClinicalTrials.gov
['NCT03003806']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1380-1384

Investigateurs

Moshe Phillip (M)
Revital Nimri (R)
Shlomit Shalitin (S)
Rachel Bello (R)
Michal Nevo-Shenker (M)
Naama Fisch-Shvalb (N)
Galit Shiovitch-Mantzuri (G)
Orit Choresh (O)
Irit Drutz (I)
Yehiel Nava (Y)
Alona Hemo (A)
Orna Hermon (O)
Rachel Nave (R)
Tadej Battelino (T)
Klemen Dovc (K)
Natasa Bratina (N)
Darja Smigoe-Schweiger (D)
Brigita Mali (B)
Ana Gianini (A)
Urska Sever (U)
Barbara Murn Berkopec (BM)
Lori M Laffel (LM)
Michelle Katz (M)
Elvira Isganaitis (E)
Sanjeev Mehta (S)
Heidi Quinn (H)
Nisha Naik (N)
Zijing Guo (Z)
Lisa Volkening (L)
Robert H Slover (RH)
Gregory Forlenza (G)
R Paul Wadwa (RP)
G Todd Alonso (GT)
Laurel Messer (L)
Lindsey Towers (L)
Katie Thivener (K)
Cari Berget (C)
Samantha Lange (S)
Emily Jost (E)
Maria Rossick-Solis (M)
Desmond Schatz (D)
Michael Haller (M)
Paul Hiers (P)
Laura Jacobsen (L)
Madison Smith (M)
Anastasia O'Neill (A)
Jennifer Hosford (J)
Alexis Perry (A)
Stuart A Weinzimer (SA)
Eda Cengiz (E)
Jennifer Sherr (J)
Kathryn Gibbons (K)
Lori Carria (L)
Melinda Zgorski (M)
Thomas Danne (T)
Torben Biester (T)
Olga Kordonouri (O)
Thekla von dem Berge (T)
Sarah Biester (S)
Kerstin Remus (K)

Références

Miller, K. M. et al. Current state of type 1 diabetes treatment in the US: updated data from the T1D exchange clinic registry. Diabetes Care 38, 971–978 (2015).
pubmed: 25998289 doi: 10.2337/dc15-0078
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993).
doi: 10.1056/NEJM199309303291401
Nathan, D. M. et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353, 2643–2653 (2005).
pubmed: 16371630 doi: 10.1056/NEJMoa052187
American Diabetes Association. Standards of medical care in diabetes—2019. Diabetes Care 42, S1–S193 (2019).
doi: 10.2337/dc19-Sint01
Foster N. C. et al. Marked increases in CGM use has not prevented increases in HbA1c levels in participants in the T1D exchange (T1DX) clinic network. Diabetes 67 (2018); https://doi.org/10.2337/db18-1689-P
Edelman, S. V., Argento, N. B., Pettus, J. & Hirsch, I. B. Clinical implications of real-time and intermittently scanned continuous glucose monitoring. Diabetes Care 41, 2265–2274 (2018).
pubmed: 30348844 doi: 10.2337/dc18-1150
Zisser, H. et al. Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-to-head-to-head comparison. Diabetes Technol. Ther. 12, 955–961 (2010).
pubmed: 21128842 doi: 10.1089/dia.2010.0064
Petitti, D. B. et al. Glycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study. J. Pediatr. 155, 668–672 (2009).
pubmed: 19643434 pmcid: 4689142 doi: 10.1016/j.jpeds.2009.05.025
The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10, 1–19 (1987).
doi: 10.2337/diacare.10.1.1
Davidson, M. B. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care 32, 370–372 (2009).
pubmed: 19171736 pmcid: 2628710 doi: 10.2337/dc08-2046
Bergenstal, R. M. et al. Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. Lancet 393, 1138–1148 (2019).
pubmed: 30808512 pmcid: 6715130 doi: 10.1016/S0140-6736(19)30368-X
Shalitin, S. et al. Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol. 51, 247–256 (2014).
pubmed: 23982170 doi: 10.1007/s00592-013-0510-x
Pihoker, C. et al. ISPAD clinical practice consensus guidelines 2018: the delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr. Diabetes 19, 84–104 (2018).
pubmed: 30144259 doi: 10.1111/pedi.12757
Chiang, J. L. et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care 41, 2026–2044 (2018).
pubmed: 30093549 pmcid: 6105320 doi: 10.2337/dci18-0023
Markowitz, J. T., Volkening, L. K. & Laffel, L. M. B. Care utilization in a pediatric diabetes clinic: cancellations, parental attendance and mental health appointments. J. Pediatr. 164, 1384–1389 (2014).
pubmed: 24612905 pmcid: 4035443 doi: 10.1016/j.jpeds.2014.01.045
Comellas, M. J. et al. Evaluation of a new digital automated glycemic pattern detection tool. Diabetes Technol. Ther. 19, 633–640 (2017).
pubmed: 29091477 pmcid: 5689116 doi: 10.1089/dia.2017.0180
Lu, H. et al. Population-based geographic access to endocrinologists in the United States, 2012. BMC Health Serv. Res. 15, 541 (2015).
pubmed: 26644021 pmcid: 4672571 doi: 10.1186/s12913-015-1185-5
Nimri, R. et al. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: variations among countries and physicians. Diabetes Obes. Metab. 20, 2458–2466 (2018).
pubmed: 29885025 doi: 10.1111/dom.13408
Beck, R. W. Downloading diabetes device data: empowering patients to download at home to achieve better outcomes. Diabetes Technol. Ther. 17, 536–537 (2015).
pubmed: 26060890 doi: 10.1089/dia.2015.0169
IDF Diabetes Atlas, 8th edn (International Diabetes Federation, accessed 3 December 2018); https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html
Patterson, C. C. et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study. Diabetologia 62, 408–417 (2019).
pubmed: 30483858 doi: 10.1007/s00125-018-4763-3
Vigersky, R. A. et al. The clinical endocrinology workforce: current status and future projections of supply and demand. J. Clin. Endocrinol. Metab. 99, 3112–3121 (2014).
pubmed: 24940655 doi: 10.1210/jc.2014-2257
Hahn, S. Understanding noninferiority trials. Korean J. Pediatr. 55, 403–407 (2012).
pubmed: 23227058 pmcid: 3510268 doi: 10.3345/kjp.2012.55.11.403
Tamborlane, W. V. et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 359, 1464–1476 (2008).
pubmed: 18779236 doi: 10.1056/NEJMoa0805017
Aleppo, G. et al. REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care 40, 538–545 (2017).
pubmed: 28209654 pmcid: 5864100 doi: 10.2337/dc16-2482
Abramson, J. H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innov. 8, 1 (2011).
pubmed: 21288353 pmcid: 3041648 doi: 10.1186/1742-5573-8-1

Auteurs

Revital Nimri (R)

The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Tadej Battelino (T)

Department of Endocrinology, Diabetes and Metabolic Diseases, UMC-University Children's Hospital Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Lori M Laffel (LM)

Joslin Diabetes Center, One Joslin Place, Harvard Medical School, Boston, MA, USA.

Robert H Slover (RH)

Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Desmond Schatz (D)

Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA.

Stuart A Weinzimer (SA)

Pediatric Endocrinology & Diabetes, Yale School of Medicine, New Haven, CT, USA.

Klemen Dovc (K)

Department of Endocrinology, Diabetes and Metabolic Diseases, UMC-University Children's Hospital Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Thomas Danne (T)

Diabetes Center for Children and Adolescents, Children's Hospital AUF DER BULT, Hannover, Germany.

Moshe Phillip (M)

The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. mosheph@tauex.tau.ac.il.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. mosheph@tauex.tau.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH